What it is (overview)

The HIV ELISA (Enzyme-Linked Immunosorbent Assay) is a commonly used blood test for HIV screening. It looks for the body’s immune response to HIV—most often HIV antibodies (proteins your immune system makes after exposure to a virus). Some modern “ELISA-based” screening tests are combined 4th-generation assays that can detect both HIV-1/2 antibodies and the p24 antigen (a part of the virus that can appear earlier than antibodies). Which version is used depends on the laboratory and your clinician’s order.

What it measures: evidence of HIV infection by detecting antibodies (and sometimes antigen) in your blood. It does not directly measure the amount of virus (that’s done with an HIV RNA/viral load test).

What results mean in plain language:

Non-reactive/Negative usually means no evidence of HIV infection was found at the time of testing. However, if testing is done soon after a potential exposure, the result may still be negative during the window period (the time before antibodies/antigen become detectable). Your clinician may recommend repeat testing or an HIV RNA test depending on timing and risk.

Reactive/Positive means the screening test detected HIV antibodies/antigen. Because screening tests can occasionally be falsely positive, a reactive ELISA is typically followed by a confirmatory test (such as an HIV-1/2 antibody differentiation immunoassay and/or an HIV RNA test) to confirm the diagnosis.

Indeterminate/Equivocal means the result wasn’t clearly positive or negative. This can happen early after exposure or due to technical factors. Repeat testing and/or confirmatory testing is usually recommended.

When & why it's usually done

HIV ELISA testing is commonly ordered as part of routine STI screening, a health check, or when someone has symptoms or risk factors that raise concern for HIV infection. Early diagnosis is important because effective treatment can protect the immune system, reduce complications, and prevent transmission.

Your clinician may recommend HIV ELISA screening if you:

• Had a possible exposure (for example, condomless sex, a partner with HIV, or sharing needles/syringes). Testing is often done initially and then repeated at an appropriate interval based on the window period and the type of test used.

• Have symptoms that could suggest acute or chronic HIV. Early (acute) HIV may cause flu-like symptoms such as fever, sore throat, rash, swollen lymph nodes, fatigue, or body aches. Later, untreated infection can lead to persistent swollen glands, recurrent infections, weight loss, night sweats, or ongoing diarrhea.

• Are pregnant or planning pregnancy. HIV screening is routinely recommended in pregnancy to protect both parent and baby and to guide timely treatment if needed.

• Have another sexually transmitted infection or a high-risk sexual history. The presence of other STIs can increase the risk of acquiring or transmitting HIV.

• Have an occupational exposure (for example, a needlestick injury in a healthcare setting) or another blood exposure. Testing helps guide follow-up and, when appropriate, post-exposure prophylaxis (PEP) monitoring.

• Are starting or using PrEP (pre-exposure prophylaxis). Regular HIV testing is required before and during PrEP to ensure HIV is not present and to support safe prevention.

• Have conditions associated with weakened immunity or unexplained lab/clinical findings (such as recurrent infections), where HIV is part of the diagnostic evaluation.

Common diseases related to it

• HIV infection (HIV-1 and HIV-2)
• Acute HIV syndrome (early HIV infection)
• Chronic HIV infection
• AIDS (Acquired Immunodeficiency Syndrome)
• Opportunistic infections related to advanced HIV (e.g., Pneumocystis pneumonia, certain fungal infections)
• Sexually transmitted infections (STIs) that may co-occur and increase HIV risk (e.g., syphilis, gonorrhea, chlamydia)

Health goals where it may help

• Routine sexual health screening and early detection of HIV
• Peace of mind after potential exposure and guidance on follow-up testing
• Protecting long-term immune system health through early diagnosis and timely treatment
• Pregnancy and prenatal health screening to reduce transmission risk
• Preventing transmission to partners through informed care and prevention strategies
• Monitoring prevention programs such as PrEP/PEP protocols with appropriate HIV testing intervals
• General wellness and health check blood test panels that include STI screening